Correction to “IMMUNOREACT 0: Biopsy‐Based Immune Biomarkers as Predictors of Response to Neoadjuvant Therapy for Rectal Cancer—A Systematic Review and Meta‐Analysis”

2026

Read Correction to “IMMUNOREACT 0: Biopsy‐Based Immune Biomarkers as Predictors of Response to Neoadjuvant Therapy for Rectal Cancer—A Systematic Review and Meta‐Analysis” (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13479108.txt.

Description

Stepanyan and colleagues published a correction in 2026 to their review of biopsy immune markers in rectal cancer. The markers might foretell how the cancer answers pre surgery drug and radiation care. The fix concerns the long list of study group members printed with the work. In the first release, each member's first and last names stood swapped. A fresh, full list in the right order is printed here. The authors voice regret for the slip, and the journal has set the online text right.

Catalog record

YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13479108

Browse the full library · About the Tower of Babel